Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by 3dollaron Jun 12, 2009 11:05am
441 Views
Post# 16065686

RE: RE: RE: Stock Trading Philosophies And Nuvo Re

RE: RE: RE: Stock Trading Philosophies And Nuvo ReWishful thinking that the company would be in a position to buy back any stock with the amount of money they may get from a partner.  They have far too many other initiatives to undertake that will eat much of their cash.  Their balance sheet would not support any type of buyback.at any point in the relative near future.

What amazes me is the lack of discussion around a buyout.  Assuming they get approval and their technology is deemed to be somewhat grounbreaking in nature why in the world would another company not want ot buy them outright while the stock price is depressed...again relatively speaking.  I'd be shocked if our management team wasn't having detailed buyout discussions in addition to a partnership agreement shoudl a purchase not be an option.

I'd be surprised if this management team is inclined to stay the course for many more years and go through the trials (no pun intended) and tribulations in will undoubtedly face as it tries to bring future products to the market.

Assuming total shares outstanding 450m.......they should be asking for $3/sh assuming FDA approval
Bullboard Posts